Catalyst Wire Dossier Catalyst Wire Dossier

Lactobacillus salivarius CECT5713

Lactobacillus salivarius CECT5713 · Puleva Biotech
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lactobacillus salivarius CECT5713, covering 2008-07-29 to 2020-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Application of Lactobacillus Salivarius CECT5713 in Infertility of Unknown Origin [Phase 2]

See pricing